Certara logo

Certara

Stock
Stock
ISIN: US15687V1098
Ticker: CERT
US15687V1098
CERT

Price

Price

CHART BY

Frequently asked questions

What is Certara's market capitalization?

The market capitalization of Certara is $1.72B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Certara?

Certara's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.194. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Certara's stock?

Currently, 11 analysts cover Certara's stock, with a consensus target price of $14.06. Analyst ratings provide insights into the stock's expected performance.

What is Certara's revenue over the trailing twelve months?

Over the trailing twelve months, Certara reported a revenue of $372.80M.

What is the EBITDA for Certara?

Certara's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $66.01M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Certara?

Certara has a free cash flow of $52.34M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Certara have, and what sector and industry does it belong to?

Certara employs approximately 1,391 people. It operates in the Health Care sector, specifically within the Packaged Software industry.

What is the free float of Certara's shares?

The free float of Certara is 111.34M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$1.72B
EPS (TTM) 
-$0.194
Free Float 
111.34M
Revenue (TTM) 
$372.80M
EBITDA (TTM) 
$66.01M
Free Cashflow (TTM) 
$52.34M

Pricing

1D span
$10.53$10.93
52W span
$9.41$19.85

Analyst Ratings

The price target is $14.06 and the stock is covered by 11 analysts.

Buy

5

Hold

6

Sell

0

Information

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Employees
1,391
Industries
Packaged Software
Sector
Health Care

Identifier

ISIN
US15687V1098
Primary Ticker
CERT

Knockouts

Join the conversation